AD: China Bulk Aspirin
The International Trade Administration (ITA) is amending its antidumping (AD) duty order, as well as its final and amended final affirmative AD duty determinations, on bulk aspirin from China as there is now a final court decision regarding this investigation.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Amendment to AD Duty Orde |
As a result of the final court decision and the ITA's subsequent remand determination, Jilin Pharmaceutical (Jilin)1 will be excluded from the AD duty order on subject merchandise from China, because the court found its AD rate to be de minimis (1.27%).
The remand determination also resulted in an AD rate for Shandong Xinhua Pharmaceutical Factory, Ltd. (Shandong) of 6.42% (from 16.51%); however, ITA sources state that this margin does not change the current zero AD cash deposit rate for Shandong, which is based on the final results of an AD administrative review for a more recent time period. The ITA adds that the China-wide AD rate is not affected by the remand determination.
Appraisement Instructions, Instructions for Jilin
The ITA states that it will issue appraisement instructions directly to U.S. Customs and Border Protection (CBP). The ITA will instruct CBP to liquidate entries from Jilin, without regard to AD duties, as Jilin is excluded from the AD order effective September 30, 2002, the date on which the ITA published a notice of court decision. (See ITT's Online Archives or 10/02/02 news, 02100240 for BP summary of this court decision.)
1 As the ITA has determined that Jilin Henghe Pharmaceutical Co. (Jilin Henghe) is the successor-in-interest to Jilin, Jilin Henghe will also be excluded from the AD duty order. (See ITT's Online Archives, or 10/29/02 news, 02102940 for BP summary of this AD duty changed circumstances review.)
(See ITT's Online Archives or 05/25/00 and 06/28/00 news, 00052440 & 00062728 for BP summaries of amended final and final AD duty determinations.)
| ITA Contact - | Blanche Ziv | (202) 482-4207 |
ITA notice (FR Pub 12/30/03) available at http://a257.g.akamaitech.net/7/257/2422/14mar20010800/edocket.access.gpo.gov/2003/pdf/03-32071.pdf